Evidence map›Paper›PMID 39526800›Full record

ArticlemSystems2024

A comprehensive two-hybrid analysis to explore the

Harley O'Connor Mount, Malene L Urbanus, Dayag Sheykhkarimli, Atina G Coté, Florent Laval, Georges Coppin, Nishka Kishore, Roujia Li, Kerstin Spirohn-Fitzgerald, Morgan O Petersen and 7 more

Abstract read
In one paragraph

Article in mSystems, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Computational function prediction of bacteria and phage proteins.Microbiology and molecular biology reviews : MMBR · 2025
    Review
  8. Review
  9. Article
  10. ThemSphere · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Harley O'Connor Mount *Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.ORCID 0000-0003-1401-9178
Malene L Urbanus *Department of Biochemistry, University of Toronto, Toronto, Ontario, Canada.ORCID 0009-0008-0850-3805
Dayag SheykhkarimliDonnelly Centre, University of Toronto, Toronto, Ontario, Canada.ORCID 0000-0001-8415-6659
Atina G CotéDonnelly Centre, University of Toronto, Toronto, Ontario, Canada.ORCID 0000-0002-0340-9325
Florent LavalCenter for Cancer Systems Biology (CCSB), Dana-Farber Cancer Institute, Boston, Massachusetts, USA.ORCID 0000-0001-7744-6199
Georges CoppinCenter for Cancer Systems Biology (CCSB), Dana-Farber Cancer Institute, Boston, Massachusetts, USA.ORCID 0000-0001-7647-3240
Nishka KishoreDonnelly Centre, University of Toronto, Toronto, Ontario, Canada.ORCID 0000-0002-9219-4310
Roujia LiDonnelly Centre, University of Toronto, Toronto, Ontario, Canada.
Kerstin Spirohn-FitzgeraldCenter for Cancer Systems Biology (CCSB), Dana-Farber Cancer Institute, Boston, Massachusetts, USA.ORCID 0000-0002-2071-1606
Morgan O PetersenDepartment of Biochemistry, University of Toronto, Toronto, Ontario, Canada.ORCID 0009-0002-2708-0090
Jennifer J KnappDonnelly Centre, University of Toronto, Toronto, Ontario, Canada.ORCID 0000-0003-3347-4686
Dae-Kyum KimDonnelly Centre, University of Toronto, Toronto, Ontario, Canada.ORCID 0000-0003-4568-8278
Jean-Claude TwizereTERRA Teaching and Research Centre, University of Liège, Gembloux, Belgium.ORCID 0000-0002-8683-705X
Michael A CalderwoodCenter for Cancer Systems Biology (CCSB), Dana-Farber Cancer Institute, Boston, Massachusetts, USA.ORCID 0000-0001-6475-1418
Marc VidalCenter for Cancer Systems Biology (CCSB), Dana-Farber Cancer Institute, Boston, Massachusetts, USA.ORCID 0000-0003-3391-5410
Frederick P RothDepartment of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.ORCID 0000-0002-6628-649X
Alexander W EnsmingerDepartment of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.ORCID 0000-0003-0824-3704

Funding

Canadian Government | Canadian Institutes of Health Research (CIHR) FDN159926Canadian Government | Canadian Institutes of Health Research (CIHR) PJT-162256Canadian Government | Natural Sciences and Engineering Research Council of Canada (NSERC)Fonds De La Recherche Scientifique - FNRS (FNRS) FC31543Fonds De La Recherche Scientifique - FNRS (FNRS) FC31747Wallonie-Bruxelles International (WBI)
6 · The paper itself

Abstract

IMPORTANCE: Secreted bacterial effector proteins are typically viewed as modulators of host activity, entering the host cytosol to physically interact with and modify the activity of one or more host proteins in support of infection. A growing body of evidence suggests that a subset of effectors primarily function to modify the activities of other effectors inside the host. These "effectors of effectors" or metaeffectors are often identified through experimental serendipity during the study of canonical effector function against the host. We previously performed the first global effector-wide genetic interaction screen for metaeffectors within the arsenal of

Indexed as

Bacterial ProteinsLegionella pneumophilaTwo-Hybrid System TechniquesHost-Pathogen InteractionsHumansLegionnaires' DiseaseProtein Interaction MappingProtein Interaction MapsType IV Secretion SystemsBacterial ProteinsType IV Secretion Systemsbacterial effectorhost–pathogenLegionella pneumophilametaeffectoryeast two-hybrid

Identifiers

PMID39526800
PMCPMC11651115

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.